Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001207151 | SCV001378491 | pathogenic | Glycogen storage disease, type II | 2022-06-22 | criteria provided, single submitter | clinical testing | This premature translational stop signal has been observed in individual(s) with Pompe disease (PMID: 24269976). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp126*) in the GAA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GAA are known to be pathogenic (PMID: 18425781, 22252923). ClinVar contains an entry for this variant (Variation ID: 938008). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. |
Baylor Genetics | RCV001207151 | SCV004195495 | pathogenic | Glycogen storage disease, type II | 2023-09-04 | criteria provided, single submitter | clinical testing |